Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Hangzhou Tigermed Consulting Co., Ltd. Class H ( (HK:3347) ).
Hangzhou Tigermed Consulting Co., Ltd. has established a Strategy Development Committee to strengthen its strategic planning and investment decision-making processes. This move aims to improve the company’s long-term development strategies and ensure effective management of significant investments, thereby potentially enhancing its market position and operational efficiency.
The most recent analyst rating on (HK:3347) stock is a Sell with a HK$37.00 price target. To see the full list of analyst forecasts on Hangzhou Tigermed Consulting Co., Ltd. Class H stock, see the HK:3347 Stock Forecast page.
More about Hangzhou Tigermed Consulting Co., Ltd. Class H
Hangzhou Tigermed Consulting Co., Ltd. operates in the consulting industry, focusing on providing strategic development services. The company is involved in making investment decisions and developing long-term strategies to enhance its core competitiveness and market positioning.
Average Trading Volume: 4,878,203
Technical Sentiment Signal: Buy
Current Market Cap: HK$55.09B
For a thorough assessment of 3347 stock, go to TipRanks’ Stock Analysis page.